February 27, 2023 |

USTR Urged To Let 4 Countries Bypass Vertex’s Trikafta IP

U.S. trade rep urged not to sanction countries if they sidestep patents on Vertex cystic fibrosis drugs
The future of HIV testing in eastern and southern Africa: Broader scope, targeted services
Related Posts
Access to Medicines

Pharma’s alleged “brea...
PEPFAR Watch

PEPFAR is Rolling the Cloc...
Access to Medicines

Pharma Pricing Secrecy Run...